---
url: https://endpoints.news/compass-reports-phase-3-depression-data-for-psilocybin-drug/
title: "Updated: Compass claims Phase 3 win in depression for psilocybin drug, yet stock plummets"
clipped: 2025-12-23 13:07
source: slack
slack_channel: mkt-research-headlines
---

# Updated: Compass claims Phase 3 win in depression for psilocybin drug, yet stock plummets

> Source: [https://endpoints.news/compass-reports-phase-3-depression-data-for-psilocybin-drug/](https://endpoints.news/compass-reports-phase-3-depression-data-for-psilocybin-drug/)

June 23, 2025 06:30 AM EDTUpdated 12:40 PM

[R&D](https://endpoints.news/channel/rd/ "Channel: R&D")

# Up­dat­ed: Com­pass claims Phase 3 win in de­pres­sion for psilo­cy­bin drug, yet stock plum­mets

### [Ayisha Sharma](https://endpoints.news/author/ayisha-sharma/ "See all stories by Ayisha Sharma")

#### News Reporter

Com­pass Path­ways said Mon­day its psilo­cy­bin drug has cleared the first of two late-stage tests in a chal­leng­ing form of de­pres­sion as it ad­vances to­ward …

![Endpoints News](https://endpoints.news/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg)

### Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

[SIGN UP](https://profile.endpoints.news/sso?mode=sign-up&r=https%3A%2F%2Fendpoints.news%2Fauth&a%5Bt%5D=L2NvbXBhc3MtcmVwb3J0cy1waGFzZS0zLWRlcHJlc3Npb24tZGF0YS1mb3ItcHNpbG9jeWJpbi1kcnVnLw%3D%3D)
[LOG IN](https://profile.endpoints.news/sso?r=https%3A%2F%2Fendpoints.news%2Fauth&a%5Bt%5D=L2NvbXBhc3MtcmVwb3J0cy1waGFzZS0zLWRlcHJlc3Npb24tZGF0YS1mb3ItcHNpbG9jeWJpbi1kcnVnLw%3D%3D)
[BECOME A PREMIUM SUBSCRIBER](https://profile.endpoints.news/upgrade)